🔴 Gain Therapeutics is trading 5% down today with no clear company-specific catalyst

Gain Therapeutics is trading at $1.23, down 5.04%, with no clear company-specific catalyst identified for its October 23, 2026 decline.

• Its latest identified announcements were an October 1 clinical-data update and an October 8 conference participation notice.
• The decline coincided with biotech-sector weakness: XBI was down 2.08% during the session amid a broader risk-off market. This provides context but does not establish a specific cause for the larger individual-stock decline.